These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25428648)

  • 1. Cytokine production associated with smallpox vaccine responses.
    Simon WL; Salk HM; Ovsyannikova IG; Kennedy RB; Poland GA
    Immunotherapy; 2014; 6(10):1097-112. PubMed ID: 25428648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
    Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
    MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smallpox vaccines for biodefense: need and feasibility.
    Artenstein AW; Grabenstein JD
    Expert Rev Vaccines; 2008 Oct; 7(8):1225-37. PubMed ID: 18844596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
    Meseda CA; Weir JP
    Future Microbiol; 2010 Sep; 5(9):1367-82. PubMed ID: 20860482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smallpox vaccination and adverse reactions. Guidance for clinicians.
    Cono J; Casey CG; Bell DM;
    MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels.
    Rock MT; Yoder SM; Talbot TR; Edwards KM; Crowe JE
    J Infect Dis; 2004 Apr; 189(8):1401-10. PubMed ID: 15073677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice.
    Nishiyama Y; Fujii T; Kanatani Y; Shinmura Y; Yokote H; Hashizume S
    Vaccine; 2015 Nov; 33(45):6120-7. PubMed ID: 26455406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination-Related Side Effects, Humoral Immunity, and Adverse Events during the Civilian Smallpox Vaccination Campaign, Arkansas, 2003.
    Haselow D
    Public Health Nurs; 2016; 33(2):129-38. PubMed ID: 26043870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice.
    Perera LP; Waldmann TA; Mosca JD; Baldwin N; Berzofsky JA; Oh S
    J Virol; 2007 Aug; 81(16):8774-83. PubMed ID: 17553867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8.
    Saito T; Fujii T; Kanatani Y; Saijo M; Morikawa S; Yokote H; Takeuchi T; Kuwabara N
    JAMA; 2009 Mar; 301(10):1025-33. PubMed ID: 19278946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse neurotoxicity test for vaccinia-based smallpox vaccines.
    Li Z; Rubin SA; Taffs RE; Merchlinsky M; Ye Z; Carbone KM
    Vaccine; 2004 Mar; 22(11-12):1486-93. PubMed ID: 15063573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine.
    Ferrier-Rembert A; Drillien R; Tournier JN; Garin D; Crance JM
    Vaccine; 2008 Mar; 26(14):1794-804. PubMed ID: 18336966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults.
    Treanor J; Wu H; Liang H; Topham DJ
    Vaccine; 2006 Nov; 24(47-48):6913-23. PubMed ID: 17014939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.
    Martínez O; Bravo Cruz A; Santos S; Ramírez M; Miranda E; Shisler J; Otero M
    Vaccine; 2017 Oct; 35(44):6007-6014. PubMed ID: 28629922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New generation smallpox vaccines: a review of preclinical and clinical data.
    Artenstein AW
    Rev Med Virol; 2008; 18(4):217-31. PubMed ID: 18283712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in IL18R1 and IL18 genes and Inteferon γ ELISPOT response to smallpox vaccination: an unexpected relationship.
    Ovsyannikova IG; Haralambieva IH; Kennedy RB; O'Byrne MM; Pankratz VS; Poland GA
    J Infect Dis; 2013 Nov; 208(9):1422-30. PubMed ID: 23901078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions.
    Casey C; Vellozzi C; Mootrey GT; Chapman LE; McCauley M; Roper MH; Damon I; Swerdlow DL; ;
    MMWR Recomm Rep; 2006 Feb; 55(RR-1):1-16. PubMed ID: 16456528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks.
    Handley L; Buller RM; Frey SE; Bellone C; Parker S
    Expert Rev Vaccines; 2009 Jul; 8(7):841-50. PubMed ID: 19538111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.